JohnFSchwerkoskeMD

PubMed

• 39 citations
  Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
  David Schiff, Kurt A. Jaeckle, S. Keith Anderson, Evanthia Galanis, Caterina Giannini, Jan C. Buckner, Phillip Stella, Patrick J. Flynn, Bradley J. Erickson, John Schw...> ;Cancer. 2018 Apr 1
• 2 citations
  A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achiev...
  Robert M. Rifkin, Andrew Greenspan, John F. Schwerkoske, Romeo A. Mandanas, Joe Stephenson, George T. Kannarkat, Feng Zhan, Kristi A. Boehm, Lina Asmar, Roy A. Beveridge> ;Investigational New Drugs. 2012 Apr 1
• 161 citations
  Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
  Bret Edward Buckley Friday, S. Keith Anderson, Jan C. Buckner, Chunrong Yu, Caterina Giannini, Francois J. Geoffroy, John Schwerkoske, Miroslaw Mazurczak, Howard Gross...> ;Neuro-Oncology. 2012 Feb 1
• 16 citations
  Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.
  Timothy M. Kuzel, Shuli Li, John W. Eklund, Francine M. Foss, Randy D. Gascoyne, Neil Abramson, John F. Schwerkoske, Edie Weller, Sandra J. Horning> ;Leukemia & Lymphoma. 2007 Oct 13
• Phase II study of denileukin diftitox for previously treated low grade non-Hodgkin's lymphoma: E1497 final report.
  Eklund JW, Weller E, Kuzel TM, Foss F, Gascoyne R, Abramson N, Schwerkoske JF, Horning S> ;J. Clin. Oncol.. 2005-06-01
• 38 citations
  Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group.
  Robert Dreicer, Judith Manola, Daniel J. Schneider, John F. Schwerkoske, Christopher S. George, Bruce J. Roth, George Wilding> ;Cancer. 2003 Jun 1
• 3 citations
  Rapid and sensitive method for the determination of salicylic acid in serum by reversed-phase ion-pair high-performance liquid chromatography.
  Stephen T. Ingalls, John F. Schwerkoske, Walter B. Forman, Charles L. Hoppel> ;Journal of Chromatography. 1983 Jan 1
• A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast c...
  Schwartzberg, L. S., Weaver, C. H., Birch, R., Manner, C., Tauer, K., Beeker, T., Morgan-Ihrig, C., MacAneny, B., Leff, R., Smith, R., Hainsworth, J., Greco, T., Schwe...> ;J Hematother. 1998 Apr
• Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.
  Weaver, C. H., Schwartzberg, L. S., Birch, R., Greco, F. A., Hainsworth, J., Drapkin, R., Campos, L., Grapski, R., Schwerkoske, J., Lautersztain, J., Hazelton, B., Sch...> ;Biol Blood Marrow Transplant. 1997 Jun
• Join now to see all